Vancomycin-resistant enterococcus (VRE) are increasingly important pathogens in stem cell transplant (SCT). In all, 61 pediatric SCT patients had surveillance stool cultures for VRE between July 1999 ...
Background: Our institution experienced an increase in the frequency of vancomycin-resistant enterococci (VRE) clinical isolates. Surveillance cultures upon hospital admission for patients at high ...
Antimicrobials with the potential to act as immune stimulators and overcome bacterial resistance are emerging as important alternative approaches to fighting antimicrobial resistance The novel ...
Vancomycin-resistant enterococcus (VRE) is among the leading causes of hospital-acquired infections in the United States. An estimated 20,000 people in the U.S. become infected with it each year, and ...
In a recent review published in the Microorganisms Journal, researchers reviewed existing data on the use of probiotics and antimicrobial peptides (AMPs) against multi-drug-resistant (MDR) bacteria, ...
A drug-resistant strain of bacteria inhabiting hospital settings has evolved to utilize an antimicrobial genetic tool. Vancomycin-resistant Enterococcus faecium (VREfm) is responsible for many lethal ...
V-161, a novel compound targeting the Na+ -V-ATPase enzyme in vancomycin-resistant Enterococcus faecium (VRE), significantly reduces bacterial growth and colonization. A recent study has demonstrated ...
The incidence of enterococcal infections has been increasing over the past few years, with rising rates of multidrug resistance. VRE is increasingly a problem in many hospitals and intensive care ...
Antibiotic resistance is a major concern, particularly for immunocompromised patients, who are at greater risk of serious infections. Microbiota composition can help prevent pathogenic bacteria from ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results